JP2020513418A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513418A5 JP2020513418A5 JP2019551494A JP2019551494A JP2020513418A5 JP 2020513418 A5 JP2020513418 A5 JP 2020513418A5 JP 2019551494 A JP2019551494 A JP 2019551494A JP 2019551494 A JP2019551494 A JP 2019551494A JP 2020513418 A5 JP2020513418 A5 JP 2020513418A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- polypeptide
- composition according
- composition
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662433490P | 2016-12-13 | 2016-12-13 | |
| US62/433,490 | 2016-12-13 | ||
| US201762466066P | 2017-03-02 | 2017-03-02 | |
| US62/466,066 | 2017-03-02 | ||
| PCT/US2017/064330 WO2018111580A1 (en) | 2016-12-13 | 2017-12-01 | Polypeptides for managing viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020513418A JP2020513418A (ja) | 2020-05-14 |
| JP2020513418A5 true JP2020513418A5 (https=) | 2021-01-14 |
Family
ID=62559193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019551494A Pending JP2020513418A (ja) | 2016-12-13 | 2017-12-01 | ウイルス感染を管理するためのポリペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10898544B2 (https=) |
| EP (2) | EP3909598A1 (https=) |
| JP (1) | JP2020513418A (https=) |
| CN (1) | CN110325206A (https=) |
| AU (1) | AU2017377993A1 (https=) |
| CA (1) | CA3046927A1 (https=) |
| MX (1) | MX2019006943A (https=) |
| WO (1) | WO2018111580A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6148233B2 (ja) | 2011-07-11 | 2017-06-21 | インディ モレキュラー，インコーポレイテッド | Ａｋｔ特異的捕捉剤、組成物ならびにその使用および製造方法 |
| CN107624115B (zh) | 2015-03-16 | 2021-10-26 | 加州理工学院 | 肉毒神经毒素特异性捕获剂、组合物、使用方法和制造方法 |
| EP3322716B1 (en) | 2015-07-15 | 2025-02-12 | California Institute of Technology | Il-17f-specific capture agents and methods of using |
| EP3440101B1 (en) | 2016-04-04 | 2021-10-06 | Indi Molecular, Inc. | Cd8-specific capture agents, compositions, and methods of using and making |
| US11884707B2 (en) | 2016-09-29 | 2024-01-30 | Regeneron Pharmaceuticals, Inc. | Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same |
| CA3046927A1 (en) | 2016-12-13 | 2018-06-21 | Emory University | Polypeptides for managing viral infections |
| WO2018232345A1 (en) | 2017-06-15 | 2018-12-20 | Indi Molecular, Inc. | Il-17f and il-17a-specific capture agents, compositions, and methods of using and making |
| US12201679B2 (en) * | 2019-04-05 | 2025-01-21 | Institute For Systems Biology | Epitope-targeted peptide immunostimulants |
| US12216122B2 (en) | 2019-05-20 | 2025-02-04 | Regeneron Pharmaceuticals, Inc. | Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1) |
| US12209142B2 (en) | 2020-05-29 | 2025-01-28 | Institute For Systems Biology | SARS-CoV-2 epitope-targeted peptide immunostimulants |
| WO2022098743A1 (en) | 2020-11-03 | 2022-05-12 | Indi Molecular, Inc. | Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1) |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US598520A (en) | 1898-02-08 | Marker s record for laundrymen | ||
| US4880078A (en) | 1987-06-29 | 1989-11-14 | Honda Giken Kogyo Kabushiki Kaisha | Exhaust muffler |
| US4966848A (en) * | 1988-02-08 | 1990-10-30 | The General Hospital Corporation | Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase |
| US5223421A (en) * | 1989-10-25 | 1993-06-29 | The General Hospital Corporation | Identification of methionine Nα-acetyltransferase |
| CA2109528A1 (en) | 1991-05-01 | 1992-11-02 | Gregory A. Prince | A method for treating infectious respiratory diseases |
| IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| US5688489A (en) * | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| US6043358A (en) | 1995-11-01 | 2000-03-28 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| ATE508733T1 (de) | 1996-03-04 | 2011-05-15 | Penn State Res Found | Materialien und verfahren zur steigerung der zellulären internalisierung |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| SE9604593D0 (sv) * | 1996-12-13 | 1996-12-13 | Sbl Vaccin Ab | Antimicrobially active polypeptides |
| CA2277801C (en) | 1997-01-16 | 2002-10-15 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| GB9718913D0 (en) | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| WO1999066903A2 (en) | 1998-06-24 | 1999-12-29 | Advanced Inhalation Research, Inc. | Large porous particles emitted from an inhaler |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US20070207209A1 (en) * | 2004-08-27 | 2007-09-06 | Murphy Christopher J | Trophic factor combinations for nervous system treatment |
| CN102448438A (zh) * | 2009-03-26 | 2012-05-09 | 普马特里克斯公司 | 抗流行性感冒调配物及方法 |
| US9464124B2 (en) * | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2755986A4 (en) * | 2011-09-12 | 2015-05-20 | Moderna Therapeutics Inc | MANIPULATED NUCLEIC ACIDS AND METHOD OF APPLICATION THEREFOR |
| US20140296137A1 (en) * | 2013-04-01 | 2014-10-02 | Los Alamos National Security, Llc | Methods and compositions for controlling rotifers |
| CA3046927A1 (en) | 2016-12-13 | 2018-06-21 | Emory University | Polypeptides for managing viral infections |
-
2017
- 2017-12-01 CA CA3046927A patent/CA3046927A1/en not_active Abandoned
- 2017-12-01 US US16/469,119 patent/US10898544B2/en active Active
- 2017-12-01 MX MX2019006943A patent/MX2019006943A/es unknown
- 2017-12-01 WO PCT/US2017/064330 patent/WO2018111580A1/en not_active Ceased
- 2017-12-01 EP EP21171750.9A patent/EP3909598A1/en not_active Withdrawn
- 2017-12-01 CN CN201780086265.XA patent/CN110325206A/zh active Pending
- 2017-12-01 JP JP2019551494A patent/JP2020513418A/ja active Pending
- 2017-12-01 EP EP17881084.2A patent/EP3554533B1/en active Active
- 2017-12-01 AU AU2017377993A patent/AU2017377993A1/en not_active Abandoned
-
2020
- 2020-12-18 US US17/127,161 patent/US11666630B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020513418A5 (https=) | ||
| JP2015517484A5 (https=) | ||
| RU2020116571A (ru) | N4-гидроксицитидин и производные и связанные с этим противовирусные применения | |
| BR112015014457A2 (pt) | composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c | |
| JP2017524682A5 (https=) | ||
| PH12017502326A1 (en) | Orodispersible dosage unit containing an estetrol component | |
| MX2022010286A (es) | Carcasas programables para encapsulacion de virus. | |
| JP2019526596A5 (https=) | ||
| RU2019105294A (ru) | Композиции и способы для модуляции передачи сигнала lair | |
| DK1578406T3 (da) | Farmaceutisk sammensætning med modificeret frigivelse | |
| JP2021530541A5 (https=) | ||
| JP2015529685A5 (https=) | ||
| US20080118556A1 (en) | Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone | |
| JP2015510393A5 (https=) | ||
| RU2018142174A (ru) | Контролируемая пищевым рационом экспрессия нуклеиновой кислоты, кодирующей нуклеазу cas9, и ее применения | |
| RU2019113989A (ru) | Лекарственное средство | |
| JP2019500379A5 (https=) | ||
| RU2018112060A (ru) | Слитый белок | |
| WO2019078663A3 (ko) | 아연염, 시클로-히스프로 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물 | |
| HRP20241042T1 (hr) | Novi analozi inzulina i njihova upotreba | |
| RU2015113031A (ru) | Использование 3-n-бутил изоиндолин кетонов при приготовлении лекарственных средств для профилактики и лечения церебрального инфаркта | |
| JP2017007966A5 (https=) | ||
| Calderón et al. | Polymeric soft nanocarriers as smart drug delivery systems: State-of-the-art and future perspectives | |
| JP2014512353A5 (https=) | ||
| JP2017008001A5 (https=) |